SLIDESHOW: 10 Stocks Crossing Below Their 200 Day Moving Average

(1) Pliant Therapeutics Breaks Below 200-Day Moving Average - Notable for PLRX triggered: 05/14/2021

Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis with an initial focus on treating fibrosis by inhibiting integrin-mediated activation of TGF-ß. Co.'s wholly-owned product candidate, PLN-74809, is an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins that Co. is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. Co.'s second product candidate, PLN-1474, is a small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with NASH, which Co. has partnered with Novartis.

PLRX — Key Stats (updated 10 HRs, 41 MINs ago)

Name:  Pliant Therapeutics Inc Website:  www.pliantrx.com Sector:  Drugs & Pharmaceuticals Number of ETFs Holding PLRX:  19 (see which ones) Total Market Value Held by ETFs:  $59,683,978.79 Total Market Capitalization:  $1,118,000,000 % of Market Cap. Held by ETFs:  5.34%

Read full article in a new window: Pliant Therapeutics Breaks Below 200-Day Moving Average - Notable for PLRX

Open the PLRX Videos Page (in a new window) »

PLRX — Current Quote

Quotes delayed 20 minutes

Avg. Broker Rec.

Strong Buy (3.80 out of 4) 73rd percentile (ranked higher than approx. 73% of all stocks covered) Based on data provided by Zacks Investment Research via Quandl.com

Featured Slideshows

10 Energy Stocks You Can Buy Cheaper Than Insiders Did Cheap Energy Stocks Paying Dividends Cheap Oil Stocks Paying Dividends Warren Buffett Energy Stocks The Top 10 DividendRank'ed Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying 10 ETFs With Stocks That Insiders Are Buying 25 Dividend Giants Widely Held By ETFs 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites Feel-Good Income: 25 Socially Responsible Dividend Stocks 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 Energy Stocks Crossing Above Their 200 DMA 10 Energy Stocks Crossing Below Their 200 DMA The 10 Biggest ETFs The 10 Best ETF Performers The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows Top 10 Analyst Rated Consumer Stocks Top 10 Analyst Rated Dividend Stocks Top 10 Analyst Rated Energy Stocks Top 10 Analyst Rated Financial Stocks Top 10 Analyst Rated Healthcare Stocks Top 10 Analyst Rated REIT Stocks Top 10 Analyst Rated Technology Stocks The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg Stock market game

Advertise on Energy Stock Channel